Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.

Guest writer Anita Newton shares how she's been coping with grief in the years since her husband, Craig, passed away due to ALS.

Faced with stress and brain fog, columnist Juliet Taylor thought that staying on top of things would keep her husband's ALS ...

Clene is scheduled to meet with the FDA in the coming months to discuss new data for CNM-Au8, its experimental oral therapy ...

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Reflecting on past journal entries reminds columnist Kristin Neva that life as an ALS caregiver is always a mix of good and hard times.

With ALS, columnist Dagmar Munn says she must focus her mind and make deliberate choices when decision-making fatigue sets in.

A bipartisan team of congressional representatives is pushing for new legislation that aims to understand why veterans are at increased… ...